XENOTHERA
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from immunomodulation to infectious diseases. Xenothera's technological platform is built on a double expertise of animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera. Xenothera’s platform ensures short-time development thanks to their mastery of the entire process, from animal genetics, choice of the immunogen, selection, and purification of interesting immunoglobulins, and access to market authorization in accelerated timescale.
XENOTHERA
Industry:
Biotechnology Genetics Therapeutics
Founded:
2014-01-01
Address:
Nantes, Pays De La Loire, France
Country:
France
Website Url:
http://www.xenothera.com
Total Employee:
1+
Status:
Active
Contact:
+33240412987
Email Addresses:
[email protected]
Total Funding:
24.35 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
iBio
iBio is a technology platform that develops pharmaceutical product applications.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Employees Featured
Founder
Investors List
Didier Rousseau
Didier Rousseau investment in Series C - Xenothera
SC NABUBOTO
SC NABUBOTO investment in Series C - Xenothera
European Innovation Council
European Innovation Council investment in Grant - Xenothera
Malakoff Humanis
Malakoff Humanis investment in Series C - Xenothera
Anaxago
Anaxago investment in Series C - Xenothera
European Innovation Council
European Innovation Council investment in Series C - Xenothera
Bpifrance
Bpifrance investment in Grant - Xenothera
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Xenothera
Starquest Capital
Starquest Capital investment in Seed Round - Xenothera
Arts et Métiers Business Angels
Arts et Métiers Business Angels investment in Seed Round - Xenothera
Official Site Inspections
http://www.xenothera.com Semrush global rank: 3.37 M Semrush visits lastest month: 4.68 K
- Host name: webcluster1.webpod17-cph3.one.com
- IP address: 46.30.215.143
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Xenothera"
Xenothera - Crunchbase Company Profile & Funding
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. Xenothera creates new therapeutic modes in numerous domains from …See details»
XENOTHERA
XENOTHERA successfully secures €4 Million non-dilutive financing from the France 2030 Public Investment Plan for its LIS22 treatment for peripheral T-Cell lymphoma. November, 2024. The …See details»
XENOTHERA - LinkedIn
XENOTHERA | 6,193 followers on LinkedIn. A Xenotherapy platform with embedded technology that renovates immunological treatments | XENOTHERA is a biotechnology company based …See details»
Pitch – XENOTHERA
XENOTHERA develops two main assets: LIS1, in Peripheral T-cell lymphoma (First Patient expected S1 2024) and in Solid Organ Transplantation and XON7, a pan-cancer GH-pAb …See details»
Team – XENOTHERA
Chairman and founder Chief Executive Officer. More FrançoiseSee details»
Xenothera 2025 Company Profile: Valuation, Funding & Investors
Xenothera General Information Description. Developer of immunosuppressants designed for transplantation and other indications. The company developed a Glyco-humanized antibody …See details»
Xenothera - Overview, News & Similar companies | ZoomInfo.com
May 30, 2023 XENOTHERA is a biotechnology start-up company which creates new therapeutic modes in immunomodulation, infectious diseases and oncology. ... which will be carried out by …See details»
Xenothera - VentureRadar
Xenothera is a biotechnology start-up company which creates new therapeutic modes in immunomodulation, infectious diseases and oncology. Our technological platform is built on a …See details»
Xenothera Company Profile - Office Locations, Competitors ... - Craft
Xenothera is a clinical-stage biotech company specializing in therapeutic for immunological treatments. It develops approaches in immunotherapy utilizing glyco-humanized polyclonal …See details»
Xenothera - Contacts, Employees, Board Members, Advisors
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.See details»
Mission – XENOTHERA
That’s why at XENOTHERA, we’re determined to get things moving. To bring disruptive and useful treatments to patients. We manufacture glyco-humanized polyclonal antibodies. More …See details»
XENOTHERA Company Profile | NANTES, PAYS DE LA LOIRE, …
Find company research, competitor information, contact details & financial data for XENOTHERA of NANTES, PAYS DE LA LOIRE. Get the latest business insights from Dun & Bradstreet.See details»
Xenothera - Funding, Financials, Valuation & Investors - Crunchbase
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Xenothera SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Xenothera SAS with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 1 news, Disease Domain:Hemic and Lymphatic Diseases, Neoplasms, Immune System …See details»
☑️Xenothera — Consulting Organization from France, …
Xenothera — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Research sectorsSee details»
XENOTHERA | Startup Profile and Investments - Bounce Watch
XENOTHERA is a biotechnology company based in France.Established in 2014, it operates with the slogan "A Xenotherapy platform with embedded technology that renovates immunological …See details»
Xenothera Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Xenothera. See Xenothera company profile and funding data.See details»
Technology – XENOTHERA
The technological platform of XENOTHERA allows the production of multispecific glyco-humanized polyclonal antibodies (GH-pAbs). Being devoid of xeno-antigens, notably Neu5Gc, …See details»
Xenothera: innovative antibodies for new perspectives in the fight ...
Dec 2, 2024 At the same time, Xenothera is making progress on other treatments that could have a major impact in oncology. XON7: This drug targets solid tumours. Clinical trials began …See details»
Treat severe cases of infection at COV with XAV-19 - CORDIS
Jan 2, 2024 Currently, XENOTHERA is working on the development of a new treatment against COVID-19 based on this technology. The product, XAV-19, is expected to treat patients …See details»